Trial Profile
Comparative Study of the Safety and Effectiveness Between Off-Label Subconjunctival Bevacizumab and Mitomycin C in Glaucoma Filtering Surgery.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Mitomycin
- Indications Glaucoma
- Focus Therapeutic Use
- 28 Feb 2017 New trial record